Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard H Calabrese

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Cleveland Clinic Journal of Medicine|May 13, 2020
Cytokine storm and the prospects for immunotherapy with COVID-19Leonard H Calabrese
Current Opinion in Rheumatology|January 11, 2020
The immunopathogenesis of rheumatic immune adverse events from checkpoint inhibitors: prospects for targeted therapyLeonard H Calabrese, Cassandra Calabrese
AIDS (London, England)|October 28, 2005
Extrahepatic immunological complications of hepatitis C virus infectionDimitrios Vassilopoulos, Leonard H Calabrese
Current Rheumatology Reports|February 26, 2013
Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCVDimitrios Vassilopoulos, Leonard H Calabrese
Nature Reviews. Rheumatology|May 9, 2012
Management of rheumatic disease with comorbid HBV or HCV infectionDimitrios Vassilopoulos, Leonard H Calabrese
Cleveland Clinic Journal of Medicine|February 2, 2021
Baricitinib and dexamethasone for hospitalized patients with COVID-19Leonard H Calabrese, Cassandra Calabrese
Rheumatic Diseases Clinics of North America|November 16, 2024
Long COVID for the Rheumatologist: Current Understanding and Approach to ManagementLeonard H Calabrese, Cassandra Calabrese
Nature Clinical Practice. Rheumatology|June 15, 2007
Biologic agents and liver toxicity: an added concern or therapeutic opportunity?Leonard H Calabrese, Nizar Zein
Current Rheumatology Reports|June 27, 2015
HCV Treatments and Their Integration Into RheumatologyDimitrios Vassilopoulos, Leonard H Calabrese
Current Rheumatology Reports|May 15, 2003
Rheumatic manifestations of hepatitis C infectionDimitrios Vassilopoulos, Leonard H Calabrese
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Cleveland Clinic Journal of Medicine|May 13, 2020
Cytokine storm and the prospects for immunotherapy with COVID-19Leonard H Calabrese
Current Opinion in Rheumatology|January 11, 2020
The immunopathogenesis of rheumatic immune adverse events from checkpoint inhibitors: prospects for targeted therapyLeonard H Calabrese, Cassandra Calabrese
AIDS (London, England)|October 28, 2005
Extrahepatic immunological complications of hepatitis C virus infectionDimitrios Vassilopoulos, Leonard H Calabrese
Current Rheumatology Reports|February 26, 2013
Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCVDimitrios Vassilopoulos, Leonard H Calabrese
Nature Reviews. Rheumatology|May 9, 2012
Management of rheumatic disease with comorbid HBV or HCV infectionDimitrios Vassilopoulos, Leonard H Calabrese
Cleveland Clinic Journal of Medicine|February 2, 2021
Baricitinib and dexamethasone for hospitalized patients with COVID-19Leonard H Calabrese, Cassandra Calabrese
Rheumatic Diseases Clinics of North America|November 16, 2024
Long COVID for the Rheumatologist: Current Understanding and Approach to ManagementLeonard H Calabrese, Cassandra Calabrese
Nature Clinical Practice. Rheumatology|June 15, 2007
Biologic agents and liver toxicity: an added concern or therapeutic opportunity?Leonard H Calabrese, Nizar Zein
Current Rheumatology Reports|June 27, 2015
HCV Treatments and Their Integration Into RheumatologyDimitrios Vassilopoulos, Leonard H Calabrese
Current Rheumatology Reports|May 15, 2003
Rheumatic manifestations of hepatitis C infectionDimitrios Vassilopoulos, Leonard H Calabrese
Pageof 14